Oral Administration of the Antimicrobial Peptide Mastoparan X Alleviates Enterohemorrhagic Escherichia coli-Induced Intestinal Inflammation and Regulates the Gut Microbiota

被引:4
|
作者
Zhao, Xue Qin [1 ,2 ]
Wang, Lei [1 ,3 ]
Zhu, Chun Ling [1 ]
Xue, Xiang Hong [3 ]
Xia, Xiao Jing [1 ]
Wu, Xi Long [4 ]
Wu, Yun Di [4 ]
Liu, Shan Qin [5 ]
Zhang, Gai Ping [1 ]
Bai, Yue Yu [1 ]
Fotina, Hanna [2 ]
Hu, Jian He [1 ]
机构
[1] Henan Inst Sci & Technol, Coll Anim Sci & Vet Med, Xinxiang, Peoples R China
[2] Sumy Natl Agrarian Univ, Fac Vet Med, Sumy, Ukraine
[3] Chinese Acad Agr Sci, Inst Special Anim & Plant Sci, Div Infect Dis Special Anim, Changchun, Peoples R China
[4] Hainan Univ, Sch Biomed Engn, State Key Lab Marine Resource Utilizat South China, Haikou, Peoples R China
[5] Henan Inst Sci & Technol, Sch Chem & Chem Engn, Xinxiang, Peoples R China
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
Antimicrobial peptide mastoparan X; Enterohemorrhagic Escherichia coli; Gut microbiota; Inflammation; Mice;
D O I
10.1007/s12602-022-10013-x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The gut microbiota plays an important role in intestinal immune system development and in driving inflammation. Antibiotic administration for therapeutic purposes causes an imbalance in the gut microbiota. Antimicrobial peptides can regulate the gut microbiota and maintain intestinal homeostasis. The aim of this study was to investigate the anti-inflammatory effects and regulation of the gut microbiota by the orally administered antimicrobial peptide mastoparan X (MPX). In this study, Escherichia coli was used to induce intestinal inflammation, and the results showed that MPX+ E. coli alleviated weight loss and intestinal pathological changes in necropsy specimens of E. coli-infected mice. MPX+ E. coli reduced the serum levels of the inflammation-related proteins interleukin-2, interleukin-6, tumour necrosis factor-alpha, myeloperoxidase, and lactate dehydrogenase on days 7 and 28. Furthermore, MPX+ E. coli increased the length of villi and reduced the infiltration of inflammatory cells into the jejunum and colon post infection. Scanning electron microscopy and transmission electron microscopy results showed that MPX could improve the morphology of jejunum villi and microvilli and increase tight junction protein levels. 16S rRNA sequencing analysis of caecal content samples showed that the species diversity and richness were lower in the E. coli-infected group. At the genus level, MPX+ E. coli significantly reduced the abundance of Bacteroidales and Alistipes and enhanced the relative abundance of Muribaculaceae. Alpha-diversity analyses (Shannon index) showed that MPX significantly increased the microbial diversity of mice. Overall, this study is the first to investigate the effects of oral administration of MPX on intestinal inflammation and the gut microbiota, providing a new perspective regarding the prevention of enteritis and maintenance of intestinal homeostasis.
引用
收藏
页码:138 / 151
页数:14
相关论文
共 50 条
  • [21] Curcumin alleviates imiquimod-induced psoriasis-like inflammation and regulates gut microbiota of mice
    Cai, Zhenguo
    Wang, Wuqing
    Zhang, Yao
    Zeng, Yibin
    IMMUNITY INFLAMMATION AND DISEASE, 2023, 11 (08)
  • [22] Oral administration of LfcinB alleviates DSS-induced colitis by improving the intestinal barrier and microbiota
    Liu, Zhineng
    Qin, Xinyun
    Nong, Keyi
    Fang, Xin
    Zhang, Bin
    Chen, Wanyan
    Wang, Zihan
    Wu, Yijia
    Shi, Huiyu
    Wang, Xuemei
    Zhang, Haiwen
    FOOD & FUNCTION, 2024, 15 (04) : 2038 - 2051
  • [23] Lasso peptide MccY alleviates non-typhoidal salmonellae-induced mouse gut inflammation via regulation of intestinal barrier function and gut microbiota
    Li, Yu
    Li, Wenjing
    Zeng, Zhiwei
    Han, Yu
    Chen, Qinxi
    Dong, Xinyi
    Wang, Zepeng
    Feng, Saixiang
    Cao, Weisheng
    MICROBIOLOGY SPECTRUM, 2023, 11 (06):
  • [24] The Therapeutic Potential of Gut-Microbiota-Derived Metabolite 4-Phenylbutyric Acid in Escherichia coli-Induced Colitis
    Wang, Kui
    Hu, Yuan
    Wu, Yu
    Xu, Jie
    Zhao, Yiyi
    Yang, Jing
    Li, Xiaobing
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (05)
  • [25] Mannan oligosaccharides selenium ameliorates intestinal mucosal barrier, and regulate intestinal microbiota to prevent Enterotoxigenic Escherichia coli-induced diarrhea in weaned piglets
    Zha, Andong
    Tu, Ruiqi
    Qi, Ming
    Wang, Jing
    Tan, Bie
    Liao, Peng
    Wu, Chenchen
    Yin, Yulong
    ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 2023, 264
  • [26] Long-term antimicrobial resistance in Escherichia coli from human intestinal microbiota after administration of clindamycin
    Nyberg, Sofia D.
    Oesterblad, Monica
    Hakanen, Antti J.
    Loefmark, Sonja
    Edlund, Charlotta
    Huovinen, Pentti
    Jalava, Jari
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2007, 39 (6-7) : 514 - 520
  • [27] Antimicrobial peptide DP7 alleviates dextran sulfate sodium (DSS)-induced colitis via modifying gut microbiota and regulating intestinal barrier function
    Zhao, Binyan
    Zhou, Hongyou
    Lin, Ke
    Xu, Jie
    Zhou, Bailing
    Xie, Daoyuan
    Ma, Jing
    Yang, Lei
    Su, Chunyan
    Yang, Li
    MEDCOMM, 2025, 6 (02):
  • [28] Recombinant antimicrobial peptide microcin J25 alleviates DSS-induced colitis via regulating intestinal barrier function and modifying gut microbiota
    Shang, Lijun
    Yu, Haitao
    Liu, Hongbin
    Chen, Meixia
    Zeng, Xiangfang
    Qiao, Shiyan
    BIOMEDICINE & PHARMACOTHERAPY, 2021, 139
  • [29] Acanthopanax senticosus polysaccharide alleviates LPS-induced intestinal inflammation in piglets by gut microbiota and hyodeoxycholic acid regulation
    Tao, Dapeng
    Dong, Yangyunyi
    Che, Dongsheng
    Wang, Zhongshen
    Zheng, Yingying
    Han, Rui
    Jiang, Hailong
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2025, 307
  • [30] D-methionine alleviates cisplatin-induced mucositis by restoring the gut microbiota structure and improving intestinal inflammation
    Wu, Cheng-Hsi
    Ko, Jiunn-Liang
    Liao, Jivan-Miaw
    Huang, Shiang-Suo
    Lin, Meei-Yn
    Lee, Ling-Hui
    Chang, Li-Yu
    Ou, Chu-Chyn
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019, 11